Health Care: Drugs

Neostem Inc (NBS: NASDAQ)

$2.13 n/a | n/a%
05/29/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 2.13
52 Week High 7.23
52 Week Low 2.03
Avg. Daily Vol. (Mil) 0.70
Beta (3 year) 1.37
Share Related Items
Mkt Cap (Mil) 85.52
Shares Out (Mil) 40.15
Float (Mil) 33.62
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.20
Current Ratio 1.70
LT Debt/ Equity 0.27
Total Debt / Equity 0.33
Valuation Ratios
Price Earnings n.a.
Price/Sales 5.01
Price/Book 1.70
Price/Cash Flow -1.50
Per Share Data
Earnings -1.71
Sales 0.42
Book Value 1.26
Cash Flow -1.46
Business Summary
Neostem Inc is a biopharmaceutical company that develops novel proprietary cell therapy products. It is engaged in the preservation & enhancement of human health through the development of cell based therapeutics that prevent, treat or cure disease.
General Information
420 Lexington Avenue
Suite 350
New York, NY 10170
Industry : Drugs
Sector: Health Care
Employees: 182
CEO: Dr. David J. Mazzo, PhD
Short Interest
Current Month (Mil) 3.12
Previous Month (Mil) 3.05
Short Interest Ratio (Days) 8.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -51.20
Return on Investments -95.40
Gross Margin 24.70
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NBS

Latest NBS Headlines from TheStreet

More Financial News for NBS

Press Releases for NBS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter